Compare
Abbott Laboratories vs Boston Scientific (ABT vs BSX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Boston Scientific (BSX) -56.8%; so far this year the figures are -12.3% and -55.2%.
Abbott Laboratories is the larger company by market value, about 3.1 times the size of Boston Scientific.
On trailing earnings, ABT trades at 40.9 times and BSX at 18.1 times.
Revenue grew +10.0% at ABT and +8.9% at BSX over the last year.
ABT yields 2.29%. BSX pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | BSX | |
|---|---|---|
| Price | $109.93 | $42.75 |
| 1-day | -3.23% | -4.23% |
| YTD | -12.26% | -55.17% |
| 1 year | -11.73% | -56.77% |
| 3 years | +15.70% | -17.25% |
| Market cap | $190.4B | $62.0B |
| P/E | 40.9 | 18.1 |
| P/S | 3.95 | 2.94 |
| P/B | 3.73 | 2.42 |
| Revenue growth | +10.00% | +8.90% |
| EPS growth | -66.20% | +26.20% |
| Gross margin % | 56.9 | 69.1 |
| Net margin % | 9.7 | 16.6 |
| ROE % | 9.2 | 13.7 |
| Debt / equity | 0.61 | 0.47 |
| FCF yield % | 3.5 | 5.4 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.22 |
| RSI (14) | 58.5 | 44.9 |
| Technical rating |